Literature DB >> 11042283

Comparison of four serological methods for the detection of diphtheria anti-toxin antibody.

J Walory1, P Grzesiowski, W Hryniewicz.   

Abstract

The aim of this study was to compare four serological methods for the detection of Corynebacterium diphtheriae IgG anti-toxin antibodies (IgG-DTAb) in human serum. One hundred serum samples were evaluated for C. diphtheriae IgG-DTAb by four different methods: passive haemagglutination (PHA), latex agglutination test (LA), toxoid enzyme-linked immunosorbent assay (Toxoid-ELISA), and toxin-binding inhibition enzyme-linked immunosorbent assay (ToBI-ELISA). As the external standardisation the neutralisation test for C. diphtheriae toxin in Vero cells (TN Vero) was used. For internal standardisation of IgG-DTAb titres, the WHO standard serum of human diphtheria antitoxin was used. The study revealed a poor correlation between the reference test and the PHA (r=0.34 Pearson's correlation coefficient), an acceptable correlation for the LA (r=0.74), a good correlation for the Toxoid-ELISA (r=0.81) and a very good correlation for ToBI-ELISA (r=0.93). The sensitivity measurements of PHA, LA, Toxoid-ELISA and ToBI-ELISA tests, were 14, 100, 94, 96% respectively and the corresponding specificity characteristics were 86, 76, 94, 90 respectively. Of the four evaluated methods, the ToBI-ELISA could be recommended for scientific and precise laboratory assays of diphtheria antibody levels in humans. For screening purposes the Toxoid-ELISA could be used, but the accuracy of antibody titres below 0.1 IU/ml, considered as the limits of protection, is questionable. Both tests offer very useful alternatives to the in vitro diphtheria toxin neutralisation test in Vero cells. Because of their unsatisfactory correlation and sensitivity as compared to the reference method, PHA and LA should be avoided and replaced by one of the two enzyme immunoassays.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042283     DOI: 10.1016/s0022-1759(00)00273-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits.

Authors:  A Faruq; L Dadson; H Cox; F Alcock; A R Parker
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

2.  External quality assessment for the determination of diphtheria antitoxin in human serum.

Authors:  Paolo Di Giovine; Antonella Pinto; Rose-Marie Olander; Dorothea Sesardic; Paul Stickings; Guy Berbers; Shona Neal; Androulla Efstratiou; Ruta Paberza; Snieguole Dauksiene; Marina Bujko; Antoaneta Detcheva; Unna Joks; Belkis Levent; Christina von Hunolstein
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

3.  Comparative seroepidemiology of diphtheria in six European countries and Israel.

Authors:  P di Giovine; G Kafatos; A Nardone; N Andrews; R M Ölander; G Alfarone; K Broughton; D Cohen; B Kriz; I Mikova; D O'Flanagan; F Schneider; I Selga; L Valinsky; I Velicko; I Karacs; R Pebody; C von Hunolstein
Journal:  Epidemiol Infect       Date:  2012-02-24       Impact factor: 4.434

4.  Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Maxim McKibben; Peter Mungai; Elisabeth McKibben; Xuelei Wang; Laura J Sutherland; Eric M Muchiri; Charles H King; Christopher L King; A Desiree LaBeaud
Journal:  PLoS Negl Trop Dis       Date:  2015-01-15

5.  Leveraging serology to titrate immunisation programme functionality for diphtheria in Madagascar.

Authors:  Solohery L Razafimahatratra; Arthur Menezes; Amy Wesolowski; Lala Rafetrarivony; Simon Cauchemez; Richter Razafindratsimandresy; Aina Harimanana; Tania Crucitti; Jean Marc Collard; C J E Metcalf
Journal:  Epidemiol Infect       Date:  2022-01-13       Impact factor: 2.451

6.  Diphtheria Antibodies and T lymphocyte Counts in Patients Infected With HIV-1.

Authors:  Francisco A B Speranza; Solange K Ishii; Luiz C S Thuler; Paulo V Damasco; Raphael Hirata; Ana L Mattos-Guaraldi; Lucimar G Milagres
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.